Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News Cell therapy company Talaris Therapeutics raises $100m in Series A round Talaris Therapeutics (formerly Regenerex) has raised $100 million in a Series A financing round to advance its allogeneic… bypharmanewsdailyMay 25, 2019